GuidelinesPrimary Care STG
Benign Prostatic Hyperplasia (BPH)
Urology
N40
DESCRIPTION
- BPH is a noncancerous (benign) growth of the prostate gland.
- May be associated with both obstructive (weak, intermittent stream and urinary hesitancy) and irritative (frequency, nocturia and urgency) voiding symptoms.
- Digital rectal examination reveals a uniform enlargement of the prostate.
- Urinary retention with a distended bladder may be present in the absence of severe symptoms, therefore it is important to palpate for an enlarged bladder during examination.
GENERAL MEASURES
- Annual follow-up with digital rectal examination.
- For patients presenting with urinary retention, insert a urethral catheter as a temporary measure while patient is transferred to hospital.
- Remove medicines that prevent urinary outflow e.g. tricyclic antidepressants, neuroleptics.
REFERRAL
- All patients with suspected BPH.
Standard Treatment Guidelines and Essential Medicines List for South Africa, Primary Healthcare, 2020-2024_Version 1.0_17 October 2024
Chapter 8: Kidney and Urological Disorders_8.7 Benign rPostatic Hyperplasia (BPH)